Comments
Loading...
Maravai LifeSciences Stock Guidance | NASDAQ:MRVI | Benzinga
Maravai LifeSciences issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/12/2025 | MRVI | Maravai LifeSciences | FY | 2025 | — | — | — | $185.00M | $205.00M | — | Get Alert |
| 02/25/2025 | MRVI | Maravai LifeSciences | FY | 2025 | — | — | — | $260.00M | $260.00M | $267.09M | Get Alert |
| 01/08/2025 | MRVI | Maravai LifeSciences | FY | 2024 | — | — | — | $260.00M | $260.00M | $260.78M | Get Alert |
| 11/07/2024 | MRVI | Maravai LifeSciences | FY | 2024 | — | — | — | $255.00M | $265.00M | $275.55M | Get Alert |
| 08/07/2024 | MRVI | Maravai LifeSciences | FY | 2024 | — | — | — | $265.00M | $285.00M | $275.44M | Get Alert |
| 05/08/2024 | MRVI | Maravai LifeSciences | FY | 2024 | — | — | — | $265.00M | $285.00M | $271.81M | Get Alert |
| 02/22/2024 | MRVI | Maravai LifeSciences | FY | 2024 | — | — | — | $265.00M | $285.00M | $261.03M | Get Alert |
| 11/07/2023 | MRVI | Maravai LifeSciences | FY | 2023 | -$0.01 | $0.01 | $0.06 | $275.00M | $285.00M | $308.73M | Get Alert |
| 08/07/2023 | MRVI | Maravai LifeSciences | FY | 2023 | $0.04 | $0.08 | $0.29 | $300.00M | $325.00M | $403.92M | Get Alert |
| 05/08/2023 | MRVI | Maravai LifeSciences | FY | 2023 | $0.27 | $0.33 | $0.35 | $400.00M | $440.00M | $430.17M | Get Alert |
| 02/22/2023 | MRVI | Maravai LifeSciences | FY | 2023 | $0.32 | $0.38 | $0.37 | $420.00M | $460.00M | $432.94M | Get Alert |
| 11/02/2022 | MRVI | Maravai LifeSciences | FY | 2022 | $1.76 | $1.80 | $1.76 | $880.00M | $890.00M | $889.97M | Get Alert |
| 08/04/2022 | MRVI | Maravai LifeSciences | FY | 2022 | $1.70 | $1.80 | $1.84 | $880.00M | $910.00M | $935.26M | Get Alert |
| 05/05/2022 | MRVI | Maravai LifeSciences | FY | 2022 | $1.74 | $1.90 | $1.77 | $920.00M | $960.00M | $942.13M | Get Alert |
| 02/23/2022 | MRVI | Maravai LifeSciences | FY | 2022 | $1.70 | $1.84 | $1.54 | $920.00M | $960.00M | $863.92M | Get Alert |
| 11/10/2021 | MRVI | Maravai LifeSciences | FY | 2021 | $1.48 | $1.52 | $1.39 | $770.00M | $780.00M | $764.03M | Get Alert |
| 11/10/2021 | MRVI | Maravai LifeSciences | FY | 2022 | — | — | — | $840.00M | $880.00M | $789.84M | Get Alert |
| 08/10/2021 | MRVI | Maravai LifeSciences | FY | 2021 | $1.30 | $1.36 | $1.15 | $745.00M | $770.00M | $709.65M | Get Alert |
| 05/10/2021 | MRVI | Maravai LifeSciences | FY | 2021 | $1.04 | $1.12 | $0.89 | $680.00M | $720.00M | $610.97M | Get Alert |
| 04/05/2021 | MRVI | Maravai LifeSciences | Q1 | 2021 | — | — | — | $147.80M | $147.80M | $135.40M | Get Alert |
| 03/02/2021 | MRVI | Maravai LifeSciences | FY | 2021 | $0.80 | $0.90 | $0.61 | $580.00M | $630.00M | $429.55M | Get Alert |
FAQ
What is the most recent guidance for Maravai LifeSciences (MRVI)?
The most recent guidance for Maravai LifeSciences (MRVI) was reported on November 7, 2023 for the full year 2023. The company provided earnings per share guidance in the range of $-0.01 to $0.01, compared to the estimated EPS of $0.06. Additionally, Maravai LifeSciences forecasted revenue between $0.28B and $0.28B for the quarter.
Browse guidance and forecast on all stocks.
